Giant Cell Arteritis

The role of temporal artery biopsy in patients with giant-cell arteritis is debated
Sergey V Moiseev, Ilya Smitienko, Nikolay Bulanov, Pavel I Novikov

Annals of the Rheumatic Diseases Apr 2019, 78 (4) e31; DOI: 10.1136/annrheumdis-2018-213282
Response to: ‘The role of temporal artery biopsy in patients with giant cell arteritis is debated’ by Moiseev et al
Christian Dejaco, Sofia Ramiro, Christina Duftner, Wolfgang A Schmidt

Annals of the Rheumatic Diseases Apr 2019, 78 (4) e32; DOI: 10.1136/annrheumdis-2018-213284
Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses
Christoph T Berger, Birke Rebholz-Chaves, Mike Recher, Tobias Manigold, Thomas Daikeler

Annals of the Rheumatic Diseases Jan 2019, annrheumdis-2018-214704; DOI: 10.1136/annrheumdis-2018-214704
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis
Young Ho Lee, Gwan Gyu Song

Annals of the Rheumatic Diseases Jan 2019, 78 (1) e9; DOI: 10.1136/annrheumdis-2017-212838
Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis
Richard Conway, Lorraine O’Neill, Geraldine M McCarthy, Conor C Murphy, Aurelie Fabre, Susan Kennedy, Douglas J Veale, Sarah M Wade, Ursula Fearon, Eamonn S Molloy

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1815-1824; DOI: 10.1136/annrheumdis-2018-213488
Response to: ‘Is the PET/CT first choice for differential diagnosis of FUO/IUO?’ by Armagan et al
Verena Schönau, Georg Schett

Annals of the Rheumatic Diseases Nov 2018, 77 (11) e83; DOI: 10.1136/annrheumdis-2017-212785
Utility of PET/CT in the diagnosis of inflammatory rheumatic diseases: a systematic review and meta-analysis
Lucie Descamps, Louis Olagne, Charles Merlin, Florent Cachin, Martin Soubrier, Sylvain Mathieu

Annals of the Rheumatic Diseases Nov 2018, 77 (11) e81; DOI: 10.1136/annrheumdis-2017-212660
Platelet activation, as measured by plasma soluble glycoprotein VI, is not associated with disease activity or ischaemic events in giant cell arteritis
Richard Conway, Anne Madigan, Niamh Redmond, Laura Helbert, Eamonn S Molloy, Eimear Dunne, Dermot Kenny, Geraldine McCarthy

Annals of the Rheumatic Diseases Nov 2018, 77 (11) 1695-1697; DOI: 10.1136/annrheumdis-2018-213487
Comparison of magnetic resonance angiography and ¹⁸F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis
Kaitlin A Quinn, Mark A Ahlman, Ashkan A Malayeri, Jamie Marko, Ali Cahid Civelek, Joel S Rosenblum, Armin A Bagheri, Peter A Merkel, Elaine Novakovich, Peter C Grayson

Annals of the Rheumatic Diseases Aug 2018, 77 (8) 1165-1171; DOI: 10.1136/annrheumdis-2018-213102
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Christian Dejaco, Sofia Ramiro, Christina Duftner, Florent L Besson, Thorsten A Bley, Daniel Blockmans, Elisabeth Brouwer, Marco A Cimmino, Eric Clark, Bhaskar Dasgupta, Andreas P Diamantopoulos, Haner Direskeneli, Annamaria Iagnocco, Thorsten Klink, Lorna Neill, Cristina Ponte, Carlo Salvarani, Riemer H J A Slart, Madeline Whitlock, Wolfgang A Schmidt

Annals of the Rheumatic Diseases May 2018, 77 (5) 636-643; DOI: 10.1136/annrheumdis-2017-212649

Main menu

Giant Cell Arteritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Giant Cell Arteritis

Pages